CTIS.eu › Drugs › N-[2-(3-Cyano-5-Fluorophenyl)-2-Methyl-1-Oxopropyl]-Beta-Alanyl-L-Alpha-Glutamylglycyl-L-Threonyl-L-Phenylalanyl-L-Threonyl-L-Seryl-L-Alpha-Aspartyl-L-Tyrosyl-L-Seryl-L-Isoleucyl-2-Methylalanyl-L-Leucyl-L-Alpha-Aspartyl-L-Lysyl-L-Isoleucyl-L-Alanyl-L-Glutaminyl-N6-[N-(19-Carboxy-1-Oxononadecyl)-L-Gamma-Glutamyl-2-[2-(2-Aminoethoxy)Ethoxy]Acetyl-2-[2-(2-Aminoethoxy)Ethoxy]Acetyl]-L-Lysyl-L-Alanyl-L-Phenylalanyl-L-Valyl-L-Glutaminyl-L-Tryptophyl-L-Leucyl-L-Isoleucyl-L-Alanylglycylglycyl-L-Prolyl-L-Seryl-L-Serylglycyl-L-Alanyl-L-Prolyl-L-Prolyl-L-Prolyl-L-Serinamide

N-[2-(3-Cyano-5-Fluorophenyl)-2-Methyl-1-Oxopropyl]-Beta-Alanyl-L-Alpha-Glutamylglycyl-L-Threonyl-L-Phenylalanyl-L-Threonyl-L-Seryl-L-Alpha-Aspartyl-L-Tyrosyl-L-Seryl-L-Isoleucyl-2-Methylalanyl-L-Leucyl-L-Alpha-Aspartyl-L-Lysyl-L-Isoleucyl-L-Alanyl-L-Glutaminyl-N6-[N-(19-Carboxy-1-Oxononadecyl)-L-Gamma-Glutamyl-2-[2-(2-Aminoethoxy)Ethoxy]Acetyl-2-[2-(2-Aminoethoxy)Ethoxy]Acetyl]-L-Lysyl-L-Alanyl-L-Phenylalanyl-L-Valyl-L-Glutaminyl-L-Tryptophyl-L-Leucyl-L-Isoleucyl-L-Alanylglycylglycyl-L-Prolyl-L-Seryl-L-Serylglycyl-L-Alanyl-L-Prolyl-L-Prolyl-L-Prolyl-L-Serinamide

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

10 Countries

Phase III

Phase III: 2

Indications tested

Sponsors using this IMP

F. Hoffmann-La Roche AG 2

All trials

2 total

A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight and type 2 diabetes Recruiting

2025-523106-32-00 Phase III 8 countries F. Hoffmann-La Roche AG
A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight without type 2 diabetes. Recruiting

2025-523104-71-00 Phase III 9 countries F. Hoffmann-La Roche AG

Showing 1–2 of 2 trials

← All drugs A–Z